Unlike traditional therapeutic CPT codes that describe exercises and manual interventions, 0770T lets providers document when XR technology is integrated into a therapy session. Code 0770T is an add-on code, meaning it is used in addition to an existing therapy code, such as Therapeutic Exercises (97110), Neuromuscular Re-Education (97112) and Gait Training (97116).Technically, what 0770T represents isn’t additional therapist time or a standalone treatment. It describes the practice expense associated with the XR technology itself, including the software, hardware use, supplies, and any technician support that makes the session possible, thus giving clinics a way to bill for XR as part of routine therapy, rather than having it treated as an experimental add-on with no billing path.

Adoption is Now a Question of When, Not If

The presence of an official CPT code - even a temporary Category III code - signals a shift in how payers and providers view XR in therapy. Category III codes are designed to track emerging technologies and help collect utilization data, but their very inclusion means:XR tools are no longer considered fringe technology; they are increasingly recognized as part of mainstream therapeutic practice and documentation. Clinics and health systems now have a standardized way to articulate the use of XR in claims, bringing clarity and consistency to billing. This also gives insurers a clear framework to discuss coverage, rather than dismissing XR as “unclassified” or experimental. For healthcare decision-makers, this shift enables meaningful measurement of utilization, outcomes, and cost data linked directly to XR adoption, supporting more informed decisions about long-term integration into care pathways.In short, CPT 0770T puts XR rehabilitation on the industry map. Even though coverage will vary by payer and region, having a recognized code removes one of the biggest historical barriers to adoption, which was uncertainty about how to bill for technology-assisted therapy.

What 0770T Means for Clinics and Patients

Because CPT 0770T must be billed alongside a primary therapy code, it reinforces a critical point: XR is an augment to clinical care, not a replacement. Payers that accept the code are essentially acknowledging that technology can enhance established therapeutic interventions, rather than replace them.  From a patient perspective, that’s encouraging. It means patients have a clearer path to accessing XR-enabled rehab as part of standard therapy rather than something experimental or out-of-pocket. That in turn helps clinicians feel more confident recommending XR tools and health systems feel more comfortable investing in them.

Where NeuroVirt Fits in the US XR Rehabilitation Landscape

As more clinics consider XR technology, choice matters. Not all platforms are created equal, and not all were developed with clinicians and patients involved from the start. NeuroVirt stands out for several important reasons:NeuroVirt has been co-designed in close collaboration with both patients and clinicians, ensuring that our use of XR is grounded in evidence-based practice.We place strong emphasis on real-time feedback and movement quality, so XR is integrated into the therapy session as a valuable clinical tool. Our platform is also built to support documentation and informed clinical decision-making, aligning well with the reporting requirements associated with CPT code 0770T.Because 0770T recognizes the practice expense of the technology itself, NeuroVirt’s clinically driven design helps clinics clearly articulate the value of adopting XR-enhanced rehabilitation within existing care pathways.The emergence of CPT code 0770T doesn’t just open the door for XR reimbursement; it invites XR solutions that are clinically grounded, measurable, and sustainable. That aligns with NeuroVirt’s core mission: to move XR rehabilitation from demonstrably beneficial to widespread standard practice.

Looking Ahead

CPT 0770T is a clear indication of a broader shift in US healthcare. What was once seen as experimental is now being documented, tracked, and reimbursed in a standardized way. As the evidence base grows and reimbursement pathways mature, XR-assisted therapy will increasingly become part of routine rehabilitation care. For providers evaluating how best to adopt this technology, options like NeuroVirt - built with clinicians and patients in mind - will be positioned to support meaningful outcomes in a landscape where adoption is no longer a question of if, but when.

‍